Toll Free: 1-888-928-9744

Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Apr, 2014 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Idenix Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Idenix Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Idenix Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Idenix Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Idenix Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

- Evaluate Idenix Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Idenix Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Idenix Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Idenix Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Idenix Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Idenix Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Idenix Pharmaceuticals, Inc. Snapshot 5
Idenix Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Idenix Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Idenix Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Idenix Pharmaceuticals, Inc. - Pipeline Products Glance 12
Idenix Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Idenix Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
IND/CTA Filed Products/Combination Treatment Modalities 14
Idenix Pharmaceuticals, Inc. - Drug Profiles 15
samatasvir 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
IDX-21437 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
IDX-21459 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
IDX-20963 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Idenix Pharmaceuticals, Inc. - Pipeline Analysis 19
Idenix Pharmaceuticals, Inc. - Pipeline Products by Target 19
Idenix Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 20
Idenix Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 21
Idenix Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 22
Idenix Pharmaceuticals, Inc. - Recent Pipeline Updates 23
Idenix Pharmaceuticals, Inc. - Dormant Projects 28
Idenix Pharmaceuticals, Inc. - Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
IDX-102 29
IDX-184 29
IDX-19368 29
IDX-19370 29
IDX-320 30
Idenix Pharmaceuticals, Inc. - Company Statement 31
Idenix Pharmaceuticals, Inc. - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38
List of Tables
Idenix Pharmaceuticals, Inc., Key Information 5
Idenix Pharmaceuticals, Inc., Key Facts 5
Idenix Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7
Idenix Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Idenix Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Idenix Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 10
Idenix Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Idenix Pharmaceuticals, Inc. - Phase II, 2014 12
Idenix Pharmaceuticals, Inc. - Phase I, 2014 13
Idenix Pharmaceuticals, Inc. - IND/CTA Filed, 2014 14
Idenix Pharmaceuticals, Inc. - Pipeline by Target, 2014 19
Idenix Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 20
Idenix Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 21
Idenix Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 22
Idenix Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 23
Idenix Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 28
Idenix Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 29
Idenix Pharmaceuticals, Inc., Other Locations 35
Idenix Pharmaceuticals, Inc., Subsidiaries 36 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify